Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-A SPECT study

NeuroImage

Volumn 40, Issue 1, 2008, Pages 275-279

  Chen, Po See ^a,b   Yang, Yen Kuang ^a,b   Yeh, Tzung Lieh ^a,b   Lee, I Hui ^a,b   Yao, Wei Jen ^a,b   Chiu, Nan Tsing ^a,b   Lu, Ru Band ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BMI; C peptide; Dopamine transporter; SPECT; TRODAT 1

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; C PEPTIDE; DOPAMINE TRANSPORTER; GLYCOSYLATED HEMOGLOBIN; INSULIN; LEPTIN; SUGAR;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MOLECULAR IMAGING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INSULIN; LEPTIN; MALE; MIDDLE AGED; NEOSTRIATUM; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REFERENCE VALUES; REGRESSION ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 38949088656     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.11.007     Document Type: Article

References (48)

1. Abizaid A., Gao Q., and Horvath T.L. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron 51 (2006) 691-702
2. Azoui R., Cuche J.L., Renaud J.F., Safar M., and Dagher G. A dopamine transporter in human erythrocytes: modulation by insulin. Exp. Physiol. 81 (1996) 421-434
3. Bornstein S.R., Schuppenies A., Wong M.L., and Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol. Psychiatry 11 (2006) 892-902
4. Bornstein S.R., Wong M.L., and Licinio J. 150 years of Sigmund Freud: what would Freud have said about the obesity epidemic?. Mol. Psychiatry 11 (2006) 1070-1072
5. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., Willett W.C., and Ascherio A. Obesity and the risk of Parkinson's disease. Am. J. Epidemiol. 159 (2004) 547-555
6. Chen P.S., Yang Y.K., Lee Y.S., Yeh T.L., Lee I.H., Chiu N.T., and Chu C.L. Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study. Psychol. Med. 35 (2005) 197-204
7. Colebrooke R.E., Humby T., Lynch P.J., McGowan D.P., Xia J., and Emson P.C. Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease. Eur. J. Neurosci. 24 (2006) 2622-2630
8. Epstein L.H., Jaroni J.L., Paluch R.A., Leddy J.J., Vahue H.E., Hawk L., Wileyto E.P., Shields P.G., and Lerman C. Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes. Res. 10 (2002) 1232-1240
9. Erixon-Lindroth N., Farde L., Wahlin T.B., Sovago J., Halldin C., and Backman L. The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res. 138 (2005) 1-12
10. Figlewicz D.P., Szot P., Chavez M., Woods S.C., and Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res. 644 (1994) 331-334
11. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., and Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 964 (2003) 107-115
12. Freeman A.S., Weddige F.K., and Lipinski Jr. J.L. Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activity. Eur. J. Pharmacol. 431 (2001) 43-46
13. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., and Flier J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51 (2006) 811-822
14. Gainetdinov R.R. Mesolimbic dopamine in obesity and diabetes. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 293 (2007) R601-R602
15. Galici R., Galli A., Jones D.J., Sanchez T.A., Saunders C., Frazer A., Gould G.G., Lin R.Z., and France C.P. Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77 (2003) 132-140
16. Gao Q., and Horvath T.L. Neurobiology of feeding and energy expenditure. Annu. Rev. Neurosci. 30 (2007) 367-398
17. Garcia B.G., Wei Y., Moron J.A., Lin R.Z., Javitch J.A., and Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol. Pharmacol. 68 (2005) 102-109
18. Hamilton M.E., and Freeman A.S. Diet and chronic haloperidol effects on rat midbrain dopamine neurons. Synapse 53 (2004) 1-5
19. Hochberg Y., and Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 9 (1990) 811-818
20. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., Thurmon J.J., Marinelli M., and DiLeone R.J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51 (2006) 801-810
21. Houseknecht K.L., Robertson A.S., Zavadoski W., Gibbs E.M., Johnson D.E., and Rollema H. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 32 (2007) 289-297
22. Huang X.F., Zavitsanou K., Huang X., Yu Y., Wang H., Chen F., Lawrence A.J., and Deng C. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav. Brain Res. 175 (2006) 415-419
23. Hwang W.J., Yao W.J., Wey S.P., and Ting G. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. J. Nucl. Med. 45 (2004) 207-213
24. Lam T.K., Gutierrez-Juarez R., Pocai A., Bhanot S., Tso P., Schwartz G.J., and Rossetti L. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13 (2007) 171-180
25. Lee S.H., Oh D.Y., Jung S.C., Kim Y.M., Cho H.K., Koh J.K., and Lee Y.S. Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia. Pharmacol. Res. 35 (1997) 447-450
26. Levin B.E. Glucose-regulated dopamine release from substantia nigra neurons. Brain Res. 874 (2000) 158-164
27. Liu Z., Wang Y., Zhao W., Ding J., Mei Z., Guo L., Cui D., and Fei J. Peptide derived from insulin with regulatory activity of dopamine transporter. Neuropharmacology 41 (2001) 464-471
28. Martel P., and Fantino M. Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol. Biochem. Behav. 53 (1996) 221-226
29. Mateos J.J., Lomena F., Parellada E., Font M., Fernandez E., Pavia J., Prats A., and Bernardo M. Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone. Rev. Esp. Med. Nucl. 25 (2006) 159-165
30. Newcomer J.W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19 Suppl. 1 (2005) 1-93
31. Owens W.A., Sevak R.J., Galici R., Chang X., Javors M.A., Galli A., France C.P., and Daws L.C. Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J. Neurochem. 94 (2005) 1402-1410
32. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci. 30 (2007) 375-381
33. Pannacciulli N., Del Parigi A., Chen K., Le D.S., Reiman E.M., and Tataranni P.A. Brain abnormalities in human obesity: a voxel-based morphometric study. NeuroImage 31 (2006) 1419-1425
34. Pelchat M.L., Johnson A., Chan R., Valdez J., and Ragland J.D. Images of desire: food-craving activation during fMRI. NeuroImage 23 (2004) 1486-1493
35. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
36. Pontieri F.E., Lattanzi R., Benincasa D., Cavallari M., Negri L., and Orzi F. Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat. Eur. J. Pharmacol. 544 (2006) 17-20
37. Porubska K., Veit R., Preissl H., Fritsche A., and Birbaumer N. Subjective feeling of appetite modulates brain activity: an fMRI study. NeuroImage 32 (2006) 1273-1280
38. Remington G. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?. Am. J. Psychiatry 163 (2006) 1132-1134
39. Rothemund Y., Preuschhof C., Bohner G., Bauknecht H.C., Klingebiel R., Flor H., and Klapp B.F. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 37 (2007) 410-421
40. Sotak B.N., Hnasko T.S., Robinson S., Kremer E.J., and Palmiter R.D. Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Res. 1061 (2005) 88-96
41. Szczypka M.S., Kwok K., Brot M.D., Marck B.T., Matsumoto A.M., Donahue B.A., and Palmiter R.D. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 30 (2001) 819-828
42. Tataranni P.A., and DelParigi A. Functional neuroimaging: a new generation of human brain studies in obesity research. Obes. Rev. 4 (2003) 229-238
43. Trinko R., Sears R.M., Guarnieri D.J., and Dileone R.J. Neural mechanisms underlying obesity and drug addiction. Physiol. Behav. 91 (2007) 499-505
44. Uehara T., Sumiyoshi T., Itoh H., and Kurachi M. Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens. Brain Res. 1133 (2007) 193-199
45. Volkow N.D., and Wise R.A. How can drug addiction help us understand obesity?. Nat. Neurosci. 8 (2005) 555-560
46. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., and Fowler J.S. Brain dopamine and obesity. Lancet 357 (2001) 354-357
47. Wang H.C., Chen P.S., Lee I.H., Yang Y.K., Yeh T.L., and Lu R.B. Rapid leptin elevation after initiation of olanzapine?. Neuropsychobiology 54 (2006) 182-185
48. Yang Y.K., Chiu N.T., Chen C.C., Chen M., Yeh T.L., and Lee I.H. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls. Psychiatry Res. 123 (2003) 191-197